DOI: https://doi.org/10.36347/sasjm.2025.v11i05.023

Pages: 509-516

Introduction: In December 2019, a series of cases of viral pneumonia caused by a new coronavirus appeared in Wuhan, China, and quickly spread to all continents, becoming a global pandemic. The disease called COVID 19 threatens the health and life of patients, especially those with a concomitant disease. Chronic hemodialysis patients represent a vulnerable population due to the high prevalence of comorbidities, namely diabetes, hypertension, immunosuppression, etc., adding to this the need to go to a hospital several times a week to receive their treatment increasing the risk of contamination. Mohammed VI University hospital center in Marrakech was the first structure in Morocco to take charge a chronic hemodialysis patient suffering from COVID 19, the aim of this analysis is therefore to describe the clinical, biological and radiological characteristics of COVID19 in chronic hemodialysis patients, but above all to address the methods of management and the various therapeutic protocols adapted to this type of patients. Materials and Methods: We conducted a multicenter prospective longitudinal study over a period of 12 months, including chronic hemodialysis patients with both first and second wave of COVID 19; in different hemodialysis centers in the Marrakech Tansift Alhaouz region. The diagnostic criteria for COVID 19 were selected according to the recommendations of the Ministry of Health.